[go: up one dir, main page]

WO2000005367A3 - Human proteins having hydrophobic domains and dnas encoding these proteins - Google Patents

Human proteins having hydrophobic domains and dnas encoding these proteins Download PDF

Info

Publication number
WO2000005367A3
WO2000005367A3 PCT/JP1999/003929 JP9903929W WO0005367A3 WO 2000005367 A3 WO2000005367 A3 WO 2000005367A3 JP 9903929 W JP9903929 W JP 9903929W WO 0005367 A3 WO0005367 A3 WO 0005367A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
hydrophobic domains
dnas encoding
dnas
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1999/003929
Other languages
French (fr)
Other versions
WO2000005367A2 (en
Inventor
Seishi Kato
Tomoko Kimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Protegene Inc
Original Assignee
Sagami Chemical Research Institute
Protegene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute, Protegene Inc filed Critical Sagami Chemical Research Institute
Priority to CA002336225A priority Critical patent/CA2336225A1/en
Priority to EP99931489A priority patent/EP1100898A2/en
Priority to AU47994/99A priority patent/AU4799499A/en
Priority to JP2000561313A priority patent/JP2002522018A/en
Publication of WO2000005367A2 publication Critical patent/WO2000005367A2/en
Publication of WO2000005367A3 publication Critical patent/WO2000005367A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides human proteins having hydrophobic domains, DNAs coding for these proteins, and expression vectors for these DNAs as well as eucaryotic cells expressing these DNAs.
PCT/JP1999/003929 1998-07-24 1999-07-22 Human proteins having hydrophobic domains and dnas encoding these proteins Ceased WO2000005367A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002336225A CA2336225A1 (en) 1998-07-24 1999-07-22 Human proteins having hydrophobic domains and dnas encoding these proteins
EP99931489A EP1100898A2 (en) 1998-07-24 1999-07-22 Human proteins having hydrophobic domains and dnas encoding these proteins
AU47994/99A AU4799499A (en) 1998-07-24 1999-07-22 Human proteins having hydrophobic domains and dnas encoding these proteins
JP2000561313A JP2002522018A (en) 1998-07-24 1999-07-22 Human protein having hydrophobic domain and DNA encoding the same

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP10/208820 1998-07-24
JP20882098 1998-07-24
JP22410598 1998-08-07
JP10/224105 1998-08-07
JP10/238116 1998-08-25
JP23811698 1998-08-25
JP25473698 1998-09-09
JP10/254736 1998-09-09
JP10/275505 1998-09-29
JP27550598 1998-09-29

Publications (2)

Publication Number Publication Date
WO2000005367A2 WO2000005367A2 (en) 2000-02-03
WO2000005367A3 true WO2000005367A3 (en) 2000-05-04

Family

ID=27529460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1999/003929 Ceased WO2000005367A2 (en) 1998-07-24 1999-07-22 Human proteins having hydrophobic domains and dnas encoding these proteins

Country Status (5)

Country Link
EP (1) EP1100898A2 (en)
JP (1) JP2002522018A (en)
AU (1) AU4799499A (en)
CA (1) CA2336225A1 (en)
WO (1) WO2000005367A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8076086B2 (en) 1999-06-29 2011-12-13 Millennium Pharmaceuticals, Inc. Methods of modulating the activity of TANGO332

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365369B1 (en) 1998-04-01 2002-04-02 Human Genome Sciences, Inc. Prostate specific secreted protein
CA2350334C (en) * 1998-11-09 2013-07-16 Centre National De La Recherche Scientifique (C.N.R.S.) New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs
US6664373B1 (en) 1999-03-01 2003-12-16 Millennium Pharmaceuticals, Inc. TWIK-5 potassium channel polypeptides and uses therefor
US6670149B1 (en) 1999-03-01 2003-12-30 Millennium Pharmaceuticals, Inc. TWIK-5 potassium channel nucleic acids and uses therefor
JP2002541804A (en) * 1999-04-09 2002-12-10 カイロン コーポレイション Secreted human protein
EP1179540A4 (en) * 1999-05-20 2002-10-09 Takeda Chemical Industries Ltd Novel polypeptide
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
EP1514933A1 (en) * 1999-07-08 2005-03-16 Research Association for Biotechnology Secretory protein or membrane protein
JP2003507065A (en) 1999-08-20 2003-02-25 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド PGRP-L polynucleotides, polypeptides, and antibodies
US6709840B1 (en) * 2000-05-11 2004-03-23 The Board Of Trustees Of The Leland Stanford Junior University Anergy associated genes
JP2004513618A (en) * 2000-07-07 2004-05-13 インサイト・ゲノミックス・インコーポレイテッド Transporters and ion channels
US20020119138A1 (en) 2001-02-26 2002-08-29 Sylvaine Cases Diacylglycerol o-acyltransferase 2alpha (DGAT2alpha)
US20030161831A1 (en) * 2001-02-23 2003-08-28 Sylvaine Cases Mono-and diacylglycerol acyltransferases and methods of use thereof
AU2002363227A1 (en) * 2001-10-31 2003-05-12 Millennium Pharmaceuticals, Inc. Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
WO2003048317A2 (en) * 2001-11-30 2003-06-12 Children's Hospital Medical Center Antibodies to magmas and uses thereof
EP1455815A4 (en) 2001-12-19 2006-11-02 Millennium Pharm Inc Human diacylglycerol acyltransferase 2 (dgat2)family members and uses therefor
EP1543018A4 (en) * 2002-08-14 2006-10-25 Lg Life Sciences Ltd Gene families associated with liver cancer
WO2004022091A1 (en) * 2002-09-06 2004-03-18 Otsuka Pharmaceutical Co., Ltd. Diacylglycerol production promoter
WO2004058971A1 (en) 2002-12-24 2004-07-15 Peking University Human cancer-relating genes, the products encoded thereby and applications thereof
US7312197B2 (en) 2003-02-24 2007-12-25 University Of Maryland, Baltimore Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
DE10345010A1 (en) * 2003-09-22 2005-04-28 Eike Staub Use of the receptor Nifie14, or nucleic acid encoding it, for detecting cancer, or the risk of developing it, also use of Nifie 14 binding agents for diagnosis and treatment of cancer
EP2070546A1 (en) 2004-04-09 2009-06-17 Takeda Pharmaceutical Company Limited Preventives/remedies for cancer
KR100954322B1 (en) * 2006-06-14 2010-04-21 주식회사 엘지생명과학 Novel LlFFL313 Gene Associated with Pancreatic Cancer
US8058014B2 (en) 2006-09-29 2011-11-15 University Of Maryland, Baltimore Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2
KR100873382B1 (en) 2006-12-21 2008-12-10 김현기 Human primary cancer gene, a protein encoded thereby, an expression vector comprising the same, and a cell transformed with the vector

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021328A2 (en) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Human proteins having transmembrane domains and dnas encoding these proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021328A2 (en) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Human proteins having transmembrane domains and dnas encoding these proteins

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
D'ANDREA ET AL: "Molecular Cloning of NKB1. A Natural Killer Cell Receptor for HLA -B Allotypes", JOURNAL OF IMMUNOLOGY, vol. 155, no. 5, 1 September 1995 (1995-09-01), pages 2306 - 2310 2310, XP002111500, ISSN: 0022-1767 *
DATABASE EMBLEMEST6 22 July 1998 (1998-07-22), STRAUSBERG R: "H. sapiens cDNA clone IMAGE:1653181 3' similar to SW:YJK4 yeast P42929 hypothetical 16.2 kD protein in SME1-MEF2 intergenic region", XP002123564 *
DATABASE EMBLEST11 25 March 1999 (1999-03-25), STRAUSBERG R: "Homo sapiens cDNA clone IMAGE:2169115 3'", XP002123566 *
DATABASE EMBLEST21 24 June 1997 (1997-06-24), HILLIER L ET AL.: "zv05b11.r1 Soares NhHMPu S1 Homo sapiens cDNA clone 7527733 5'similar to SW:YJK4 yeast P42929 hypothetical 16.2 kD protein in SME1-MEF2 intergenic region", XP002123565 *
GILLEN C M ET AL: "Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human.", JOURNAL OF BIOLOGICAL CHEMISTRY., vol. 271, no. 27, 5 July 1996 (1996-07-05), AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD., US, pages 16237 - 16244, XP002119528, ISSN: 0021-9258 *
KYTE J ET AL: "A SIMPLE METHOD FOR DISPLAYING THE HYDROPATHIC CHARACTER OF A PROTEIN", JOURNAL OF MOLECULAR BIOLOGY, vol. 157, no. 1, 5 May 1982 (1982-05-05), pages 105 - 132, XP000609692, ISSN: 0022-2836 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8076086B2 (en) 1999-06-29 2011-12-13 Millennium Pharmaceuticals, Inc. Methods of modulating the activity of TANGO332

Also Published As

Publication number Publication date
WO2000005367A2 (en) 2000-02-03
EP1100898A2 (en) 2001-05-23
CA2336225A1 (en) 2000-02-03
JP2002522018A (en) 2002-07-23
AU4799499A (en) 2000-02-14

Similar Documents

Publication Publication Date Title
WO2000005367A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2000029448A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU4189799A (en) Prostate growth-associated membrane proteins
EP0825260A3 (en) Arginase II
AU2002228972A1 (en) Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof
AU5264498A (en) Genes encoding telomerase proteins
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
ZA995201B (en) Stabilized protein compositions.
ZA9710288B (en) Novel genes encoding telomerase proteins.
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2001049713A3 (en) Stabilizing peptides, polypeptides and antibodies which include them
CA2336261A1 (en) Cyclin e2 genes and proteins
WO1999058558A3 (en) Cell signaling proteins
WO2001004297A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO1999043802A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
AU6063900A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
ZA99677B (en) Placental protein 13.
WO1999035263A3 (en) Il-17rh dna and polypeptides
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU3310399A (en) Leptospiral outer membrane protein, lipl32
AU7753700A (en) Dna encoding prost 07 polypeptide
AU6844596A (en) Nucleotide sequence encoding the cd33-like protein
WO2001000824A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2000019210A3 (en) Determining the mechanism of beta-amyloid peptide generation
EP1045914B8 (en) Testis-specific human svph1-8 proteinase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 561313

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref document number: 2336225

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1999931489

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999931489

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09743247

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999931489

Country of ref document: EP